Opentrons

SOSV Closes $306M Deep Tech Fund for Human and Planetary Health

Retrieved on: 
Tuesday, April 16, 2024
Opentrons, Investment, Seed, BSL, AI, Doctor of Philosophy, Climate, Health, NotCo, Khosla Ventures, HAX, ESD, University, Female, Therapy, Pennsylvania Plaza, Dwight (The Walking Dead), Empire, Robotics, Drug discovery, Vertical, Empire State Development Corporation, Cryptocurrency

PRINCETON, N.J., April 16, 2024 /PRNewswire/ -- SOSV , a multi-stage deep tech venture investor, today announced the close of its $306 million SOSV V fund, the firm's largest fund to date.

Key Points: 
  • PRINCETON, N.J., April 16, 2024 /PRNewswire/ -- SOSV , a multi-stage deep tech venture investor, today announced the close of its $306 million SOSV V fund, the firm's largest fund to date.
  • SOSV V will focus on deep tech startups in human and planetary health, with an emphasis on the intertwined imperatives of decarbonization and re-industrialization—part of the fund's mandate to "reinvent the means of production"—even as SOSV continues to pioneer investments in health ranging from therapeutics to medical devices.
  • "As the first check in deep tech, SOSV represents the start of the journey for hundreds of deep tech founders," said Sean O'Sullivan, SOSV's founding and managing general partner.
  • Active deep tech co-investors in SOSV portfolio companies welcomed the SOSV V news.

Genie Life Sciences Partners with Opentrons® to Provide New Lab Execution Software for Opentrons Robots

Retrieved on: 
Tuesday, January 30, 2024
Science, Software, Other Science, Biotechnology, Health, Robotics, Health Technology, Technology, Partnership, Workflow, Jinn, Research, Data management, Automation, Exhibition, SLAS, Opentrons, OT-2, Conference

Genie Life Sciences, a provider of laboratory workflow execution software, has announced a partnership with Opentrons Labworks, Inc., a provider of open-source liquid handling robots, to bring a new user-friendly, robust, and agile software solution for operating Opentrons lab robots and modules.

Key Points: 
  • Genie Life Sciences, a provider of laboratory workflow execution software, has announced a partnership with Opentrons Labworks, Inc., a provider of open-source liquid handling robots, to bring a new user-friendly, robust, and agile software solution for operating Opentrons lab robots and modules.
  • Genie LabOS is a software platform that makes it simple to design, manage, and orchestrate your entire lab automation workflow.
  • Pairing Genie LabOS with the Opentrons FlexTM or OT-2 allows for end-to-end instrument control, experiment planning, and data management.
  • Opentrons will be exhibiting at booth #1216 and Genie Life Sciences will be exhibiting at booth #109.

Genie Life Sciences Announces a New Software Integration with the Opentrons OT-2 and Flex Lab Robots

Retrieved on: 
Monday, October 30, 2023
Software, Other Health, General Health, Mobile, Wireless, Internet, Robotics, Electronic Design Automation, Technology, Health Technology, Science, Biotechnology, Health, Other Science, ASHG, Jinn, Society, American Society of Human Genetics, Annual general meeting, API, Workflow, Human genetics, Opentrons, Cryptocurrency, Nintendo Labo, Python

Genie Life Sciences, a provider of cloud-connected laboratory orchestration solutions, announced today a new integration with the Opentrons OT-2 and Flex Lab Robots on its software platform, Genie LabOS.

Key Points: 
  • Genie Life Sciences, a provider of cloud-connected laboratory orchestration solutions, announced today a new integration with the Opentrons OT-2 and Flex Lab Robots on its software platform, Genie LabOS.
  • This feature will allow Genie customers to natively control the Opentrons OT-2 and Flex Lab Robots through Genie LabOS, software that provides a single solution to design, manage, and orchestrate your entire lab automation workflow.
  • Designed for all experience levels in the automation space, LabOS makes it easy to control all instrumentation in your lab.
  • “We are excited for the release of the Opentrons products in the Genie LabOS platform.

First Mice Engineered to Survive COVID-19 Like Young, Healthy Humans

Retrieved on: 
Wednesday, November 1, 2023
Wyss Institute, Neoplasm, ACE, ACE2, National Institutes of Health, Adenine, Opentrons, CDI, TP53, Obesity, Biochemistry, Human, DNAS, CRISPR, Genetics, G.H. Raisoni Department of Microbiology and Biotechnology, NYU Langone Health, Diabetes, Q-system (genetics), Doctor of Philosophy, Infection, Genetic code, Fungus, Cell, Wyss Institute for Biologically Inspired Engineering, Research, NYU, Mouse, Sol, Genome, COVID-19, Cancer, Guanine, New York University Grossman School of Medicine, Gene, Pharmacology, Cytosine, Patient, Bangladesh Technical Education Board, Mutation, AG, DNA, Vaccine, Pathology, Nature

NEW YORK, Nov. 1, 2023 /PRNewswire/ -- Researchers have genetically engineered the first mice that get a human-like form of COVID-19, according to a study published online November 1 in Nature.

Key Points: 
  • NEW YORK, Nov. 1, 2023 /PRNewswire/ -- Researchers have genetically engineered the first mice that get a human-like form of COVID-19, according to a study published online November 1 in Nature.
  • The mice with this genetic change developed symptoms similar to young humans infected with the virus causing COVID-19, instead of dying upon infection as had occurred with prior mouse models.
  • "This has been a major missing piece in efforts to develop new drugs against this virus."
  • Boeke also receives consulting fees and royalties from OpenTrons, and holds equity in the company.

Revolutionizing Liquid Biopsy: Zymo Research and Opentrons Partner to Automate Novel Cell-Free DNA Isolation Chemistry

Retrieved on: 
Monday, July 24, 2023
DNA, Partnership, Methylation, Nucleic acid thermodynamics, Workflow, NGS, DNA sequencing, Liquid biopsy, Business, Research, Collection, Robotics, Fluid mechanics, Automation, Fine chemical, Vaccine, Opentrons

IRVINE, Calif., July 24, 2023 /PRNewswire/ -- Zymo Research Corp, a leading provider of life science technologies, has partnered with Opentrons Labworks, Inc., a leader in lab automation, to revolutionize cell-free DNA isolation and analysis. The collaboration brings an innovative fully automated, comprehensive workflow from sample collection through library preparation transforming liquid biopsy analysis.

Key Points: 
  • IRVINE, Calif., July 24, 2023 /PRNewswire/ -- Zymo Research Corp , a leading provider of life science technologies, has partnered with Opentrons Labworks, Inc., a leader in lab automation, to revolutionize cell-free DNA isolation and analysis.
  • Current, common methods of liquid biopsy extraction can be challenging for cancer research due to inefficient recovery of cell-free DNA.
  • The Zymo Research and Opentrons partnership offers a new approach that overcomes the hurdles of these common methods.
  • Zymo Research will be at booth #3089 and Opentrons will be at booth #1978.

Opentrons Hires Gautam Prabhu as CTO to Accelerate Automated Lab Robotics Engineering Solutions

Retrieved on: 
Tuesday, July 18, 2023
Software as a service, Lincoln L-head V12 engine, PagerDuty, Zendesk, Neochromosome, Flex, Robotics, Growth, Automation, Data science, Management, Industrial design, Engineering, Opentrons

BROOKLYN, N.Y., July 18, 2023 /PRNewswire/ -- Opentrons Labworks, Inc., a leader in lab automation and makers of accessible lab robotics, today announced the appointment of Gautam Prabhu as Chief Technology Officer. With over two decades of experience leading software engineering organizations, Mr. Prabhu is poised to play a pivotal role in the company's expansion of its Opentrons Robotics and Neochromosome Business Units. As CTO, Mr. Prabhu will accelerate product development across Opentrons' data science and engineering teams and ensure the successful implementation of the company's roadmap. He also will serve as the company's representative in technology-focused discussions with the board of directors and investors.

Key Points: 
  • BROOKLYN, N.Y., July 18, 2023 /PRNewswire/ -- Opentrons Labworks, Inc ., a leader in lab automation and makers of accessible lab robotics, today announced the appointment of Gautam Prabhu as Chief Technology Officer.
  • With over two decades of experience leading software engineering organizations, Mr. Prabhu is poised to play a pivotal role in the company's expansion of its Opentrons Robotics and Neochromosome Business Units.
  • As CTO, Mr. Prabhu will accelerate product development across Opentrons' data science and engineering teams and ensure the successful implementation of the company's roadmap.
  • "The technical teams for Opentrons Robotics and Neochromosome are pushing the boundaries of automation and engineering in the life sciences industry," Mr. Prabhu said.

Opentrons partners with Zymo Research to automate key microbiome chemistries on the Opentrons Flex™

Retrieved on: 
Thursday, June 15, 2023
Partnership, Agriculture, Collaboration, Business, Collection, Risk, Research, Robotics, Health, Automation, Instrumentation, Opentrons

IRVINE, Calif. and BROOKLYN, N.Y., June 15, 2023 /PRNewswire/ -- Opentrons Labworks, Inc., a leader in lab automation and makers of accessible lab robotics and Zymo Research Corp, a life science reagent company, are collaborating to transform microbiome and metagenome analysis by fully automating comprehensive, end-to-end workflows from sample collection through library preparation on the Opentrons Flex.

Key Points: 
  • The innovative collaboration between Zymo and Opentrons, which combines the automation capabilities of the Opentrons Flex platform with Zymo chemistries, offers numerous advantages over conventional approaches, including enhanced throughput, minimized variability, and superior data quality.
  • The Opentrons Flex platform enables the ability to perform multiple chemistries simultaneously, significantly reducing the risk of sample loss, contamination, or variability.
  • "By streamlining and standardizing microbiome analysis through the combined use of the Opentrons Flex platform and Zymo's chemistries, this partnership can accelerate the progress and influence of microbiome research.
  • Zymo and Opentrons have a successful history of collaboration, having automated popular Zymo chemistries, including ZymoBIOMICS, Quick-DNA, and Direct-Zol™ chemistries on Opentrons' reliable and affordable personal pipetting robot, the OT-2.

Opentrons Flex™ Lab Robot Launches to Accelerate Bioautomation Across Thousands of Life Science Experiments

Retrieved on: 
Monday, May 22, 2023
Molecular biology, Medicinal chemistry, Mayo Clinic, University, Biochemistry, University of Michigan, Use of Free and Open-Source Software (FOSS) in the U.S. Department of Defense, Workflow, Smartphone, API, Research, MIT, Genomics, Harvard University, Proteomics, Assistant, Flex, U.S. Department of Energy, Office of Inspector General, Argonne, Traction, Khosla Ventures, Algorithm, Internal medicine, Argonne National Laboratory, Medical school, Biology, AI, Clinical professor, OEM, Robotics, Automation, 3D printing, Typesetting, Fine chemical, Opentrons

Brooklyn, N.Y., May 22, 2023 /PRNewswire/ -- Opentrons, a leader in lab automation, announces the launch of its Opentrons Flex robot, a new generation of affordable and easy-to-program liquid-handling lab robots designed to level the playing field for labs of all sizes and bring advanced lab automation to more researchers than ever before. Fusing advanced robotics with a deep ecosystem of open-source software, the Flex is compatible with AI tools and has near-limitless potential to learn new protocols. The new product builds on the momentum the company has with customers including the Mayo Clinic, Harvard, and MIT.

Key Points: 
  • The new product builds on the momentum the company has with customers including the Mayo Clinic, Harvard, and MIT.
  • Opentrons' mission is to empower scientists to get more lab work done the way they want.
  • "By making lab automation as easy as using a smartphone, the Flex robot democratizes access to automation in life sciences research."
  • Opentrons also has OEM partnerships through which customers can leverage its hardware and software stack capabilities.

PerkinElmer alum James Atwood joins Opentrons Labworks to drive robotics innovations and enable accessible, affordable laboratory automation

Retrieved on: 
Wednesday, April 12, 2023
NGS, Microfluidics, Growth, Knowledge, PerkinElmer, Laboratory, Research, Atwood, Genomics, Management, Opentrons

BROOKLYN, N.Y., April 12, 2023 /PRNewswire/ -- Opentrons Labworks, Inc., a life sciences company at the forefront of the Laboratory 4.0 movement, today announced the appointment of James Atwood as General Manager of its Opentrons Robotics Business Unit. With Atwood's expertise in genomics and laboratory research tool development, the company is in a strong position as it expands commercialization of its OT-2 liquid-handling robot and prepares for the next generation of advanced lab automation robots.

Key Points: 
  • As General Manager, Atwood will leverage experience in sales and product management within the life science sector to solidify Opentrons' position as a leader in laboratory automation.
  • BROOKLYN, N.Y., April 12, 2023 /PRNewswire/ -- Opentrons Labworks, Inc ., a life sciences company at the forefront of the Laboratory 4.0 movement, today announced the appointment of James Atwood as General Manager of its Opentrons Robotics Business Unit.
  • "We are excited to welcome James during this exciting period of growth," said Jonathan Brennan-Badal, CEO of Opentrons.
  • Before joining Opentrons, Atwood was vice president of the omics business division of genomics tool company MOBILion Systems.

ValueSelling Associates Welcomes Greg Brown as Managing Partner

Retrieved on: 
Friday, March 17, 2023
DNA, IPO, Partnership, PeopleSoft, Marketing, Opentrons, RVP, Salesforce, Partner (business rank), Management, Apttus

CARLSBAD, Calif., March 17, 2023 (GLOBE NEWSWIRE) -- ValueSelling Associates, Inc. announces its partnership with Greg Brown as a new Managing Partner, based in northern California.

Key Points: 
  • CARLSBAD, Calif., March 17, 2023 (GLOBE NEWSWIRE) -- ValueSelling Associates, Inc. announces its partnership with Greg Brown as a new Managing Partner, based in northern California.
  • Greg joined each of these companies in their very early stages (pre-IPO) and helped them grow into market leaders.
  • President and CEO of ValueSelling Associates, Julie Thomas, said, “Greg Brown has been instrumental in building and leading top-performing enterprise sales teams, creating new markets, building and executing sales and marketing strategy and growing strategic partner relationships throughout his career.
  • Since then, Greg has helped thousands of sales professionals incorporate ValueSelling into their revenue DNA.